tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Holding ENTA?
Track your performance easily

Enanta Pharmaceuticals (ENTA) Ownership - Who Owns Enanta Pharmaceuticals?

159 Followers

Enanta Pharmaceuticals (ENTA) Ownership Overview

7.02%13.51%31.93%10.88%36.66%
31.93% Other Institutional Investors
10.88% ETFs
36.66% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail, and individual investors. Approximately 56.32% of the company’s stock is owned by Institutional Investors, 7.02% is owned by Insiders, and 36.66% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 15, 2023
Terry Vance
Director
xxxxxxxxxxxxx
$139490
Dec 06, 2023
xxxxxxxxxxxxx
$5142
Dec 06, 2023
Tara Lynn Kieffer
Chief Product Strategy Officer
xxxxxxxxxxxxx
$20464
Dec 06, 2023
xxxxxxxxxxxxx
$23228

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$21841594

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,108,262Institution9.95%19,627,919
1,084,707Institution5.12%10,098,622
911,208Institution4.30%8,483,346
837,931Institution3.95%7,801,138
810,609Insider3.83%7,546,770
451,416Institution2.13%4,202,683
373,295Insider1.76%3,475,376
229,925Institution1.09%2,140,602
218,575Institution1.03%2,034,933
147,827Institution0.70%1,376,269

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
911,208Institution4.30%8,483,346
451,416Institution2.13%4,202,683
229,925Institution1.09%2,140,602
218,575Institution1.03%2,034,933
147,827Institution0.70%1,376,269
119,191Institution0.56%1,109,668
104,837Institution0.49%976,032
96,222Institution0.45%895,827
84,628Institution0.40%787,887
82,642Institution0.39%769,397

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
629,597Institution2.97%7,079,818
552,687Institution2.61%5,145,516
281,611Institution1.33%3,166,716
190,879Institution0.90%1,777,083
91,731Institution0.43%1,031,515
36,202Institution0.17%940,890
94,375Institution0.45%856,925
66,420Institution0.31%746,893
54,407Institution0.26%494,016
46,595Institution0.22%433,799

FAQ

Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 31.93% of the company's stock is held by institutional investors, 7.02% is held by insiders, and 36.66% is held by retail investors.
    What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 31.93% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
      What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 36.66% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
        Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
        Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis